Oncoloxía médica
Servizo
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublicacións en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (7)
2021
-
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
BMC Cancer, Vol. 21, Núm. 1
-
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
BMC Cancer, Vol. 21, Núm. 1
2020
2019
-
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132
2016
2013
-
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial
Annals of Oncology, Vol. 24, Núm. 2, pp. 448-453
2003
-
Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer
Medical Oncology, Vol. 20, Núm. 1, pp. 37-43